Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.21.1
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current:    
Cash and cash equivalents $ 68,724 $ 79,107
Restricted cash 451 353
Accounts receivable, net 1,737 1,676
Prepaids, advances and other 3,334 3,174
Other receivables 1,552 1,306
Inventories, net 11,555 10,190
Total current assets 87,353 95,806
Investment – Cansativa 1,542 1,553
Property, plant and equipment, net of accumulated depreciation of $3,915 and $3,356 for the three months ended March 31, 2021 and December 31, 2020, respectively 27,336 25,680
Intangible assets, net 23,889 24,279
Goodwill 18,508 18,508
Other non-current assets 59 52
Total Assets 158,687 165,878
Current:    
Accounts payable 3,430 4,429
Accrued expenses and other current liabilities 3,447 4,865
Warrant liability 23,912 19,061
Deferred revenue 218 870
Total current liabilities 31,007 29,225
Convertible notes 27,266 27,142
Loans and borrowings 7,924 6,701
Deferred revenue 1,782 1,167
Deferred tax liabilities 5,700 5,700
Other long-term liabilities 563 693
Total Liabilities 74,242 70,628
Shareholders’ equity    
Common shares, without par value, unlimited shares authorized: 25,583,588 and 24,883,024 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 0 0
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of March 31, 2021 and December 31, 2020 0 0
Additional paid-in capital 167,224 164,264
Accumulated deficit (82,779) (69,014)
Total equity attributable to shareholders 84,445 95,250
Total liabilities and shareholders' equity $ 158,687 $ 165,878